![](/img/cover-not-exists.png)
A Cost Analysis of the Prevention of End-stage Renal Disease: Immunoglobulin Therapy for IgA Nephropathy
Durand-Zaleski, I., Bastuji-Garin, S., Zaleski, S., Weil, B., Rostoker, G.Volume:
16
Language:
english
Journal:
Medical Decision Making
DOI:
10.1177/0272989X9601600403
Date:
October, 1996
File:
PDF, 653 KB
english, 1996